Advanced Enzyme Technologies Stock Shares Owned By Institutions
| ADVENZYMES | 332.35 5.90 1.74% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Advanced Enzyme's long-term financial health and intrinsic value.
Advanced | Shares Owned By Institutions |
Advanced Enzyme Technologies Company Shares Owned By Institutions Analysis
Advanced Enzyme's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Current Advanced Enzyme Shares Owned By Institutions | 20.59 % |
Most of Advanced Enzyme's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Enzyme Technologies is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
| Competition |
Based on the latest financial disclosure, 20.59% of Advanced Enzyme Technologies are shares owned by institutions. This is 25.48% lower than that of the Chemicals sector and 65.15% lower than that of the Materials industry. The shares owned by institutions for all India stocks is 47.49% higher than that of the company.
Advanced Shares Owned By Institutions Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Enzyme's direct or indirect competition against its Shares Owned By Institutions to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Advanced Enzyme could also be used in its relative valuation, which is a method of valuing Advanced Enzyme by comparing valuation metrics of similar companies.Advanced Enzyme is currently under evaluation in shares owned by institutions category among its peers.
Advanced Fundamentals
| Return On Equity | 0.0944 | ||||
| Return On Asset | 0.0626 | ||||
| Profit Margin | 0.20 % | ||||
| Operating Margin | 0.25 % | ||||
| Current Valuation | 32.29 B | ||||
| Shares Outstanding | 111.88 M | ||||
| Shares Owned By Insiders | 56.01 % | ||||
| Shares Owned By Institutions | 20.59 % | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 5.66 X | ||||
| Revenue | 6.37 B | ||||
| Gross Profit | 4.87 B | ||||
| EBITDA | 2.27 B | ||||
| Net Income | 1.31 B | ||||
| Cash And Equivalents | 667.5 M | ||||
| Total Debt | 393.5 M | ||||
| Book Value Per Share | 127.00 X | ||||
| Cash Flow From Operations | 1.49 B | ||||
| Earnings Per Share | 12.03 X | ||||
| Target Price | 440.0 | ||||
| Number Of Employees | 338 | ||||
| Beta | 0.37 | ||||
| Market Capitalization | 37.84 B | ||||
| Total Asset | 16.21 B | ||||
| Retained Earnings | 11.53 B | ||||
| Working Capital | 7.83 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 16.21 B | ||||
| Last Dividend Paid | 1.2 |
About Advanced Enzyme Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Enzyme Technologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Enzyme using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Enzyme Technologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Advanced Stock Analysis
When running Advanced Enzyme's price analysis, check to measure Advanced Enzyme's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Enzyme is operating at the current time. Most of Advanced Enzyme's value examination focuses on studying past and present price action to predict the probability of Advanced Enzyme's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Enzyme's price. Additionally, you may evaluate how the addition of Advanced Enzyme to your portfolios can decrease your overall portfolio volatility.